NIJS DE, HENRIK,CHANDLER, SUSAN,PERRY, ELIZABETH ANNE,FERDINANDO, JOSEPHINE JOAN CHRISTINE
申请号：
HU0200453
公开号：
HU229455B1
申请日:
2000.03.27
申请国别(地区):
HU
年份:
2013
代理人:
摘要：
Disclosed is a pharmaceutical formulation in the form of a capsule for oral administration comprising testosterone undecanoate as an active ingredient dissolved in a pharmaceutically acceptable liquid carrier, characterised in that the liquid carrier comprises at least 50 % by weight of castor oil. The choice of castor oil as the liquid carrier, in conjunction with the choice of testosterone undecanoate as the androgen, makes for a solution which can comprise about 200-250 mg/ml of TU. This is a novel achievement for any orally administerable solution of testosterone. The solution may also contain a lipophilic surfactant such as lauroglycol.
